Paris-based Metyos has secured $2.5 million in pre-seed funding from Cenitz.
The startup is developing a wearable device for patients to manage their chronic kidney disease.
Check out the 8-slide pitch deck it used to raise the funding.
AdvertisementMedtech startup Metyos has secured $2.5 million in pre-seed funding from French investor Cenitz.
The Paris-based startup, which launched in 2021, is creating a remote biosensor that patients can use to track their chronic kidney disease (CKD).
Persons:
Metyos, —, Cenitz
Organizations:
Service, Business
Locations:
Paris, Cenitz